Last edition
News about "Hansoh Pharma "
Hansoh Pharma Expands Indications for Merigolix with Initiation of ART Development
Hansoh Pharma recently received approval for an IND (Investigational New Drug) application targeting ART, expanding the development area of merigolix.
Hansoh Pharma | 21/03/2025 | By Aishwarya
Merck Signs Exclusive Global License Deal with Hansoh Pharma for Oral GLP-1 Receptor Agonist
Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535.
Hansoh Pharma | 19/12/2024 | By Aishwarya | 213
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy